Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M49.6Revenue $M0.2Net Margin (%)-8,857.9Z-Score-8.0
Enterprise Value $M35.1EPS $-0.1Operating Margin %-9,694.9F-Score4
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-8,857.9Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %0Quick Ratio3.7Cash flow > EarningsY
Price/Sales2205-y EBITDA Growth Rate %-0.9Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-54.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-61.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M215ROI % (ttm)-49.0Gross Margin Increase y-yY

Gurus Latest Trades with HEB

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

HEB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


HEB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Equels Thomas K.CFO, Vice Chairman, Secretary 2015-04-15Buy100,000$0.23-4.35 view
STRAYER DAVID RMedical Director 2012-05-18Buy50,000$0.26-15.38 view
Lander Russel JVP of Process/QualityAssurance 2011-03-01Buy50,000$0.46-52.17 view
Lander Russel JVP of Process/QualityAssurance 2010-08-23Buy4,910$0.51-56.86 view
CARTER WILLIAM ACEO, 10% Owner 2010-08-10Sell377,388$0.49-55.1 view
STRAYER DAVID RMedical Director 2010-06-23Sell50,900$0.55-60 view
STRAYER DAVID RMedical Director 2010-06-16Buy230,586$0.57-61.4 view
Bernhardt Charles Thomas IIICFO 2010-06-15Sell87,794$0.59-62.71 view
Springate Wayne S.Vice President of Operations 2010-06-15Sell83,104$0.59-62.71 view
CARTER WILLIAM ACEO, 10% Owner 2010-06-11Buy500,000$0.66-66.67 view

Press Releases about HEB :

    Quarterly/Annual Reports about HEB:

    News about HEB:

    Articles On GuruFocus.com
    Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
    Hemispherx Biopharma Inc Reports Operating Results (10-K/A) Feb 14 2011 
    Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
    Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
    Hemispherx Biopharma Inc Reports Operating Results (10-Q) Nov 08 2010 
    Weekly CEO Sells Highlight: Hemispherx Biopharma Inc, ADESA Inc, Entergy Corp, and Danaher Corp. Aug 15 2010 
    Hemispherx Biopharma Inc Reports Operating Results (10-Q) Aug 06 2010 
    Hemispherx Biopharma Inc (HEB) CEO William A Carter buys 500,000 Shares Jul 01 2010 
    Weekly CFO Buys Highlight: Wireless Telecom Group, ValueVision Media, American River Bankshares, Hem Dec 13 2009 
    Hemispherx Biopharma Inc (HEB) CFO Charles Thomas Iii Bernhardt buys 2,000 Shares Dec 08 2009 

    More From Other Websites
    Coverage initiated on Hemispherx Biopharma by Midtown Partners Apr 02 2015
    HEMISPHERX BIOPHARMA INC Financials Mar 26 2015
    Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion on Application for Orphan... Mar 24 2015
    Hemispherx Biopharma to Present Data on the Activity of Ampligen(R) Against the Ebola Virus Mar 23 2015
    HEMISPHERX BIOPHARMA ANNOUNCES FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2014 . . . Newly... Mar 20 2015
    Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2014 Mar 20 2015
    HEMISPHERX BIOPHARMA INC Files SEC form 10-K, Annual Report Mar 19 2015
    Hemispherx Uses Ebola Tragedy to Raise Cash, Pay Executive Bonuses Mar 10 2015
    Hemispherx Enters a Collaboration with Emerge Health for the Commercialization of Ampligen for... Mar 09 2015
    Hemispherx Biopharma Announces the Completion of the Newly Upgraded Alferon® Facility: Commercial... Mar 02 2015
    Hemispherx Biopharma Announces the Completion of the Newly Upgraded Alferon(R) Facility: Commercial... Mar 02 2015
    Hemispherx Biopharma: Institute of Medicine, the Health Arm of the US National Academy of Sciences... Feb 23 2015
    Hemispherx Biopharma: Institute of Medicine, the Health Arm of the US National Academy of Sciences... Feb 23 2015
    Hemispherx Biopharma and USAMRIID to Present New Discoveries Concerning the Efficacy of Ampligen®... Feb 12 2015
    Hemispherx Biopharma and USAMRIID to Present New Discoveries Concerning the Efficacy of Ampligen(R)... Feb 12 2015
    Hemispherx Biopharma Posts USAMRIID Ebola Study Concluding Ampligen(R) Produced 100% Survival Rate... Feb 09 2015
    U.S. Army Medical Researchers to Hemispherx: We're Really Not That Into You Feb 04 2015
    Hemispherx: U.S. Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate in Ebola... Feb 02 2015
    USAMRIID Reports Genetic Changes in Ebola Virus May Impede Potential Treatments Jan 26 2015
    Hemispherx Biopharma Awarded $770,852 by Federal Judge Jan 15 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK